Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TET2 anticorps (N-Term)

L’anticorps Lapin Polyclonal anti-TET2 a été validé pour WB et EIA. Il convient pour détecter TET2 dans des échantillons de Humain.
N° du produit ABIN1450172

Aperçu rapide pour TET2 anticorps (N-Term) (ABIN1450172)

Antigène

Voir toutes TET2 Anticorps
TET2 (Tet Methylcytosine Dioxygenase 2 (TET2))

Reactivité

  • 54
  • 24
  • 16
Humain

Hôte

  • 47
  • 8
  • 1
Lapin

Clonalité

  • 48
  • 8
Polyclonal

Conjugué

  • 32
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TET2 est non-conjugé

Application

  • 33
  • 18
  • 11
  • 10
  • 7
  • 7
  • 6
  • 5
  • 5
  • 3
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Épitope

    • 13
    • 12
    • 8
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    N-Term

    Réactivité croisée (Details)

    Species reactivity (tested):Human.

    Purification

    Affinity chromatography purified via peptide column

    Immunogène

    18 amino acid synthetic peptide near the amino terminus of Human TET2

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS containing 0.02 % Sodium Azide as preservative

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène

    TET2 (Tet Methylcytosine Dioxygenase 2 (TET2))

    Autre désignation

    TET2

    Sujet

    TET2, a member of the ten-eleven-translocation (TET) family of genes, is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. It is a candidate tumor suppressor gene reported to be mutated in approximately 14 % of patients with JAK2V617F-positive myeloproliferative neoplasms, and can be mutated in other hematopoietic disorders such as myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. Analysis of the TET2 and JAK2 mutations in these neoplasms suggests that mutations in TET2 do not represent a predisposition for acquiring mutations in JAK2.Synonyms: KIAA1546, Methylcytosine dioxygenase TET2

    ID gène

    54790

    NCBI Accession

    NP_001120680

    Pathways

    L'effet Warburg
Vous êtes ici:
Chat with us!